Contribution: Industrial Research Assistance Program – Contributions to Firms
NoNO Inc.
$515,620.00
Pharmacokinetic profile of Nerinetide (NA-1) and Plasmin Resistant PSD-95 Inhibitors in cynomolgus macaques.
FY 2018-19 · 2018-12-01
Summary
This proposal focuses on translating academic discoveries into new treatments for stroke recovery and chronic neurological diseases that constitute massive socioeconomic burdens in Canada and worldwide. It provides a foundation for a biotechnology industry in Ontario to address these issues and build wealth in our province.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
861256576
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-12-01 | 2018-19 | $499,620.00 |
| 1 | 2018-12-01 | 2018-19 | $499,620.00 |
| 2 | 2018-12-01 | 2018-19 | $515,620.00 |
| 3 | 2018-12-01 | 2018-19 | $515,620.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 62 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 62 jours.
Agreement End Date
2020-08-31
Agreement Number
925290
Agreement Start Date
2018-12-01
Agreement Title
Pharmacokinetic profile of Nerinetide (NA-1) and Plasmin Resistant PSD-95 Inhibitors in cynomolgus macaques.
Agreement Title (French)
Profil pharmacocinétique du nerinetide (NA-1) et des inhibiteurs PSD-95 résistants à la plasmine chez le macaque de Buffon
Agreement Type
Contribution
Agreement Value
$515,620.00
Amendment Date
2020-07-02
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This proposal focuses on translating academic discoveries into new treatments for stroke recovery and chronic neurological diseases that constitute massive socioeconomic burdens in Canada and worldwide. It provides a foundation for a biotechnology industry in Ontario to address these issues and build wealth in our province.
Description (French)
Cette proposition vise à convertir des découvertes scientifiques en nouveaux traitements pour la réadaptation des victimes d'accidents vasculaires cérébraux et pour les maladies neurologiques chroniques qui constituent un fardeau socio-économique énorme au Canada et dans le monde. Elle jette les bases d'une industrie de la biotechnologie en Ontario qui permettra de résoudre ces problèmes et de contribuer à la création de richesses dans notre province.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Spadina--Fort York
Federal Riding (French)
Spadina--Fort York
Federal Riding Number
35101
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
861256576
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
NoNO Inc.
Recipient Postal Code
M5V 1E7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q4-925290
